Molecular Profiling of Benign Vocal Fold Lesions: Differential Gene Expression in Polyps versus Reinke’s Edema

Highlights

• Vocal fold polyps (VFP) exhibit significant upregulation of COL1A1, FN1, and MMP-9 compared to Reinke’s edema (RE), suggesting distinct extracellular matrix (ECM) remodeling pathways.
• Differential expression of ECM-related genes may serve as molecular biomarkers to assist in the diagnosis of histologically similar benign laryngeal lesions.
• Chronic inflammation and tissue remodeling processes are central to the pathogenesis of both VFP and RE, yet the fibroblastic activity appears more pronounced in VFP.
• The integration of RT-qPCR and FDR correction methodologies provides a robust framework for identifying pathophysiological differences in phonotraumatic injuries.

Background

Benign vocal fold lesions (BVFLs), including vocal fold polyps (VFP) and Reinke’s edema (RE), represent a significant portion of laryngeal pathologies encountered in clinical practice. While both conditions lead to dysphonia and impaired vocal quality, they are traditionally distinguished by their clinical presentation and etiology. Vocal fold polyps are typically unilateral, appearing as pedunculated or sessile masses following acute phonotrauma or vocal abuse. In contrast, Reinke’s edema is characterized by a diffuse, gelatinous swelling of the superficial lamina propria (Reinke’s space), most commonly associated with chronic smoking and gastroesophageal reflux.

Despite these clinical distinctions, VFP and RE share striking histological similarities. Both involve disruptions in the extracellular matrix (ECM), varying degrees of edema, and vascular changes. In many cases, microscopic examination of tissue biopsies reveals overlapping features such as basement membrane thickening and collagen deposition, making definitive diagnosis challenging for pathologists. Understanding the underlying molecular mechanisms—specifically how gene expression profiles differ—is essential for improving diagnostic accuracy and developing targeted therapeutic interventions.

Key Content

Differential Gene Expression in Extracellular Matrix (ECM) Synthesis

The extracellular matrix of the vocal fold is a complex scaffold of proteins and glycosaminoglycans that determines its biomechanical properties. In a pivotal cross-sectional study by Iravani et al. (2026), the expression of six key genes involved in ECM maintenance and inflammation was compared between patients with VFP (n=12) and RE (n=10).

Two major structural genes, COL1A1 (Collagen Type I Alpha 1) and FN1 (Fibronectin 1), were found to be significantly upregulated in vocal fold polyps compared to Reinke’s edema. COL1A1 encodes the pro-alpha1 chain of type I collagen, the most abundant collagen in the body, providing tensile strength to tissues. Its elevated expression in polyps suggests a more robust and localized fibroblastic response to injury. Fibronectin (FN1) is a glycoprotein that plays a critical role in cell adhesion and migration during wound healing. Its upregulation in VFP further supports the hypothesis that polyps represent an active, organized wound-healing response to mechanical stress.

Proteolytic Activity and Matrix Remodeling

The balance between ECM synthesis and degradation is regulated by Matrix Metalloproteinases (MMPs). The study highlighted a significant increase in MMP-9 (Gelatinase B) expression in vocal fold polyps relative to Reinke’s edema. MMP-9 is known to degrade type IV collagen, a major component of the basement membrane, and is heavily involved in tissue remodeling and leukocyte migration.

The higher expression of MMP-9 in VFP suggests that polyps undergo more dynamic tissue turnover or structural breakdown compared to the relatively stagnant, fluid-filled nature of Reinke’s space in RE. This molecular distinction reflects the active remodeling seen in polyps versus the chronic, diffuse swelling characteristic of RE.

Inflammatory Cytokines and Exploratory Findings

Inflammation is a hallmark of both VFP and RE, yet the specific cytokine profiles have remained elusive. The study investigated IL-1β (Interleukin-1 beta) and IL-8 (Interleukin-8), two potent pro-inflammatory mediators. While nominal differences were observed, these did not survive False Discovery Rate (FDR) correction (q < 0.01). Similarly, COL3A1 (Collagen Type III) showed no significant difference after correction. These results suggest that while inflammation is present in both pathologies, the acute inflammatory signaling pathways (at the mRNA level) might be similar between the two, or that larger cohorts are needed to detect subtle differences in cytokine expression.

Expert Commentary

The findings of Iravani et al. (2026) represent a significant step toward “Molecular Laryngology.” The ability to differentiate VFP from RE at a transcriptomic level provides clinicians with more than just a diagnostic tool; it provides a window into the biological behavior of the lesion.

From a clinical perspective, the upregulation of COL1A1 and FN1 in VFP may explain why polyps tend to be more discrete and firm, whereas RE remains edematous. This also suggests that surgical excision of a polyp might require different precision techniques compared to the “stringing” or volume-reduction techniques used in RE. Furthermore, the elevation of MMP-9 in polyps could potentially be targeted in the future using topical inhibitors to reduce the recurrence of lesions post-surgery.

However, limitations exist. The sample sizes (12 VFP and 10 RE) are relatively small, and the study lacked a healthy control group for baseline comparison. Additionally, mRNA levels do not always correlate directly with protein levels or enzymatic activity. Future research should include proteomic analysis and longitudinal studies to see how these expression levels change following voice therapy or surgical intervention.

Conclusion

In summary, the molecular landscape of vocal fold polyps is characterized by a significantly higher expression of genes related to ECM production (COL1A1, FN1) and degradation (MMP-9) compared to Reinke’s edema. These findings provide a mechanistic basis for the histological differences observed in clinical practice and offer promising avenues for the development of molecular diagnostics. As we move toward precision medicine in otolaryngology, identifying these gene signatures will be vital for improving patient outcomes and tailoring treatments to the specific biological drivers of laryngeal disease.

References

• Iravani K, Azarpira N, Dara M, Asadian F, Falamarzi K, Akhtari M. Gene Expression Differences Between Vocal Fold Polyps and Reinke’s Edema. The Laryngoscope. 2026-03-13. PMID: 41826056.